- Home
- IFRX vs FLNT Comparison
IFRX vs FLNT Comparison
Compare IFRX & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- FLNT
- Stock Information
- Founded
- IFRX 2007
- FLNT 2001
- Country
- IFRX Germany
- FLNT United States
- Employees
- IFRX N/A
- FLNT N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- FLNT Advertising
- Sector
- IFRX Health Care
- FLNT Consumer Discretionary
- Exchange
- IFRX Nasdaq
- FLNT Nasdaq
- Market Cap
- IFRX 53.5M
- FLNT 43.4M
- IPO Year
- IFRX 2017
- FLNT N/A
- Fundamental
- Price
- IFRX $0.83
- FLNT $2.26
- Analyst Decision
- IFRX Strong Buy
- FLNT Hold
- Analyst Count
- IFRX 4
- FLNT 1
- Target Price
- IFRX $7.75
- FLNT $3.00
- AVG Volume (30 Days)
- IFRX 198.5K
- FLNT 24.2K
- Earning Date
- IFRX 08-07-2025
- FLNT 08-22-2025
- Dividend Yield
- IFRX N/A
- FLNT N/A
- EPS Growth
- IFRX N/A
- FLNT N/A
- EPS
- IFRX N/A
- FLNT N/A
- Revenue
- IFRX $191,224.00
- FLNT $243,850,000.00
- Revenue This Year
- IFRX N/A
- FLNT N/A
- Revenue Next Year
- IFRX $1,276.37
- FLNT $11.62
- P/E Ratio
- IFRX N/A
- FLNT N/A
- Revenue Growth
- IFRX 54.36
- FLNT N/A
- 52 Week Low
- IFRX $0.71
- FLNT $1.50
- 52 Week High
- IFRX $2.82
- FLNT $3.83
- Technical
- Relative Strength Index (RSI)
- IFRX 44.92
- FLNT 51.82
- Support Level
- IFRX $0.74
- FLNT $2.15
- Resistance Level
- IFRX $0.86
- FLNT $2.48
- Average True Range (ATR)
- IFRX 0.07
- FLNT 0.28
- MACD
- IFRX -0.00
- FLNT -0.01
- Stochastic Oscillator
- IFRX 44.02
- FLNT 31.30
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.